Dexbrompheniramine and phenylephrine and Olaratumab Intravenous
Determining the interaction of Dexbrompheniramine and phenylephrine and Olaratumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexbrompheniramine / phenylephrine
Brand name: Ala Hist PE, Ala-Hist PE
Synonyms: Dexbrompheniramine and Phenylephrine
Generic Name: olaratumab
Brand name: Lartruvo
Synonyms: Olaratumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexbrompheniramine and phenylephrine-Oleptro
- Dexbrompheniramine and phenylephrine-Oleptro Oral
- Dexbrompheniramine and phenylephrine-Olmesartan
- Dexbrompheniramine and phenylephrine-Olmesartan and Hydrochlorothiazide
- Dexbrompheniramine and phenylephrine-Olmesartan Medoxomil
- Dexbrompheniramine and phenylephrine-Olmesartan Medoxomil and Hydrochlorothiazide
- Olaratumab Intravenous-Dexbrompheniramine and Phenylephrine Syrup
- Olaratumab Intravenous-Dexbrompheniramine and Phenylephrine Tablets
- Olaratumab Intravenous-Dexbrompheniramine and pseudoephedrine
- Olaratumab Intravenous-Dexbrompheniramine and Pseudoephedrine Solution
- Olaratumab Intravenous-Dexbrompheniramine and Pseudoephedrine Sustained-Release Tablets
- Olaratumab Intravenous-Dexbrompheniramine and Pseudoephedrine Tablets